Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CCT244747 |
Trade Name | |
Synonyms | SYN-1216 |
Drug Descriptions |
CCT244747 inhibits CHK1, potentially resulting in increased tumor cell death and increased sensitivity to other antitumor agents (PMID: 22929806, PMID: 27422809, PMID: 28131548). |
DrugClasses | CHK1 Inhibitor 18 |
CAS Registry Number | 1404095-34-6 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CCT244747 | CCT244747 | 0 | 0 |
CCT244747 + Gemcitabine | CCT244747 Gemcitabine | 1 | 0 |
CCT244747 + Irinotecan | CCT244747 Irinotecan | 0 | 0 |
CCT244747 + Paclitaxel + Radiotherapy | CCT244747 Paclitaxel Radiotherapy | 1 | 0 |
CCT244747 + Radiotherapy | CCT244747 Radiotherapy | 1 | 0 |